Caitong International Asset Management »

Relmada Therapeutics shares owned by Caitong International Asset Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Caitong International Asset Management from 13F filings

Historical chart of Caitong International Asset Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Caitong International Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $250 36 6.97

More positions owned by Caitong International Asset Management

Lumentum Hldgs (LITE)
Axt (AXTI)
Venture Global Com Cl A (VG)
Marvell Technology (MRVL)
Palantir Technologies Cl A (PLTR)
Petroleo Brasileiro S A Sponsored Adr (PBR)
Exxon Mobil Corporation (XOM)
CF Industries Holdings (CF)
Cheniere Energy Com New (LNG)
Petroleo Brasileiro S A Sp Adr Non Vtg (PBR.A)
Lam Research Corp Com New (LRCX)
Chevron Corporation (CVX)
SLB Com Stk (SLB)
Visa Com Cl A (V)
Apple (AAPL)

View all positions for Caitong International Asset Management

Top funds holding Relmada Therapeutics

Henderson Group
Squadron Capital Management
VR Adviser
OrbiMed Advisors
Adage Capital Partners GP
Millennium Management
Marshall Wace
Vanguard Capital Management
RA Capital Management
Ikarian Capital
Driehaus Capital Management
BlackRock
Vanguard Group
Opaleye Management
Geode Capital Management

View all funds holding Relmada Therapeutics